TruScreen Group Limited (TRU.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -2.05 Million NZD | 14.63% |
| 2023 | -2.4 Million NZD | 69.57% |
| 2022 | -7.89 Million NZD | -126.15% |
| 2021 | -3.49 Million NZD | 32.84% |
| 2020 | -5.19 Million NZD | -48.37% |
| 2019 | -3.5 Million NZD | 21.7% |
| 2018 | -4.47 Million NZD | -26.34% |
| 2017 | -3.54 Million NZD | -173.0% |
| 2016 | -1.29 Million NZD | -87.4% |
| 2015 | -692.07 Thousand NZD | 70.8% |
| 2014 | -2.37 Million NZD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -678.18 Thousand NZD | -14.8% |
| 2024 Q3 | -347.08 Thousand NZD | 48.82% |
| 2024 FY | -2.05 Million NZD | 14.63% |
| 2024 Q2 | -678.18 Thousand NZD | 0.0% |
| 2024 Q4 | -347.08 Thousand NZD | 0.0% |
| 2023 Q2 | -610.16 Thousand NZD | 0.0% |
| 2023 Q3 | -590.75 Thousand NZD | 3.18% |
| 2023 Q1 | -610.16 Thousand NZD | 81.6% |
| 2023 FY | -2.4 Million NZD | 69.57% |
| 2023 Q4 | -590.75 Thousand NZD | 0.0% |
| 2022 Q4 | -3.31 Million NZD | 0.0% |
| 2022 FY | -7.89 Million NZD | -126.15% |
| 2022 Q3 | -3.31 Million NZD | -426.94% |
| 2022 Q2 | -629.45 Thousand NZD | 0.0% |
| 2022 Q1 | -629.45 Thousand NZD | 36.41% |
| 2021 Q1 | -755.08 Thousand NZD | 63.89% |
| 2021 FY | -3.49 Million NZD | 32.84% |
| 2021 Q2 | -755.08 Thousand NZD | 0.0% |
| 2021 Q4 | -989.92 Thousand NZD | 0.0% |
| 2021 Q3 | -989.92 Thousand NZD | -31.1% |
| 2020 Q3 | -2.09 Million NZD | -311.9% |
| 2020 Q2 | -507.58 Thousand NZD | 0.0% |
| 2020 FY | -5.19 Million NZD | -48.37% |
| 2020 Q4 | -2.09 Million NZD | 0.0% |
| 2020 Q1 | -507.58 Thousand NZD | 55.03% |
| 2019 Q3 | -1.12 Million NZD | -101.03% |
| 2019 Q1 | -561.48 Thousand NZD | 53.28% |
| 2019 Q2 | -561.48 Thousand NZD | 0.0% |
| 2019 Q4 | -1.12 Million NZD | 0.0% |
| 2019 FY | -3.5 Million NZD | 21.7% |
| 2018 FY | -4.47 Million NZD | -26.34% |
| 2018 Q3 | -1.2 Million NZD | -36.16% |
| 2018 Q4 | -1.2 Million NZD | 0.0% |
| 2018 Q1 | -882.61 Thousand NZD | 4.91% |
| 2018 Q2 | -882.61 Thousand NZD | 0.0% |
| 2017 Q2 | -842.06 Thousand NZD | 0.0% |
| 2017 Q4 | -928.23 Thousand NZD | 0.0% |
| 2017 FY | -3.54 Million NZD | -173.0% |
| 2017 Q3 | -928.23 Thousand NZD | -10.23% |
| 2017 Q1 | -842.06 Thousand NZD | -78.24% |
| 2016 Q1 | -176.03 Thousand NZD | -74.72% |
| 2016 FY | -1.29 Million NZD | -87.4% |
| 2016 Q3 | -472.43 Thousand NZD | -168.37% |
| 2016 Q4 | -472.43 Thousand NZD | 0.0% |
| 2016 Q2 | -176.03 Thousand NZD | 0.0% |
| 2015 Q2 | -245.28 Thousand NZD | 0.0% |
| 2015 Q3 | -100.75 Thousand NZD | 58.92% |
| 2015 FY | -692.07 Thousand NZD | 70.8% |
| 2015 Q4 | -100.75 Thousand NZD | 0.0% |
| 2015 Q1 | -245.28 Thousand NZD | 0.0% |
| 2014 FY | -2.37 Million NZD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 94.301% |
| Adherium Limited | -10.22 Million AUD | 79.944% |
| Aroa Biosurgery Limited | -9.74 Million AUD | 78.965% |
| Atomo Diagnostics Limited | -6.84 Million AUD | 70.056% |
| Anteris Technologies Ltd | -67.33 Million AUD | 96.955% |
| Control Bionics Limited | -5.91 Million AUD | 65.326% |
| CardieX Limited | -6.76 Million AUD | 69.691% |
| Compumedics Limited | -338 Thousand AUD | -506.667% |
| Cochlear Limited | 356.8 Million AUD | 100.575% |
| CleanSpace Holdings Limited | -3.12 Million AUD | 34.428% |
| Cyclopharm Limited | -4.7 Million AUD | 56.379% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | 24.878% |
| Nova Eye Medical Limited | -8.79 Million AUD | 76.672% |
| HeraMED Limited | -6.78 Million AUD | 69.773% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 90.937% |
| ImpediMed Limited | -19.79 Million AUD | 89.639% |
| InhaleRx Limited | -1.44 Million AUD | -42.075% |
| LBT Innovations Limited | -3.74 Million AUD | 45.173% |
| Micro-X Limited | -9.76 Million AUD | 79.001% |
| Neurotech International Limited | -5.06 Million AUD | 59.55% |
| OncoSil Medical Limited | -11.91 Million AUD | 82.788% |
| PolyNovo Limited | 5.26 Million AUD | 138.976% |
| Respiri Limited | -7.12 Million AUD | 71.238% |
| SomnoMed Limited | -12.24 Million AUD | 83.25% |
| Universal Biosensors, Inc. | -6.74 Million AUD | 69.584% |
| Uscom Limited | -2.07 Million AUD | 1.167% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | 59.502% |